← Leaderboards
Vardan T. Karamyan
Texas Tech University Health Scis Center
$1,187,161
Attributed
$3,561,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $645.6K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,561,482 · 1
By mechanism
R01$3,561,482 · 1
Top collaborators
- Thomas J Abbruscato6 shared
- Paul Trippier6 shared
Most similar at Texas Tech University Health Scis Center
Same institution · by research overlap
- Thomas J Abbruscato$7,448,916
- Volker Neugebauer$13,630,118
Others in their field
Other Emerging Leaders on “Experimental Study”
- John Hobbs · Suny At Stony Brook$42,194,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Christopher Bee · Suny At Stony Brook$41,239,084
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,024,342
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,835,102
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Experimental StudyExtracellularEffective TherapyExperimental ModelsAngiotensin IiDrug DevelopmentDrug DiscoveryDrug KineticsDoseEquilibriumBench To BedsideBradykininBrainBindingCause Of DeathDrug CandidateBiochemicalClinically RelevantClinical ResearchBiochemistryBlood - Brain Barrier AnatomyEnzymesDesignFamily
Grant awards (6)
Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy$645,589
R01 · FY2025 · NS · contact PI
Development and Characterization of Peptidomimetic Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy$578,588
R01 · FY2022 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2021 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2020 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2019 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$601,070
R01 · FY2018 · NS · contact PI